Idiopathic Pulmonary Fibrosis Flashcards

1
Q

what happens in IPF?

A

get scarring of the lungs with collagen deposition and honeycombing.

The lung tries to repair lung tissue by laying down scar tissue when it doesn’t need repaired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

who gets IPF?

A

more common in males and smokers

It is late onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the pathology of IPF?

A

chronic inflammatory infiltrate (neutrophils and fibrosis in alveolar walls or without intra-alveolar macrophages)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why does IPF not respond to steroid treatment?

A

it is NOT an inflammatory disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the cause of IPF?

A
  • as yet unknown -there is an imbalance in the fibrotic repair system
  • could be related to gastric reflux, acid from the stomach causing damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are other secondary causes of pulmonary fibrosis ?

A
  • rheumatoid arthritis, SLE, systemic sclerosis, asbestos

- drugs: amiodarone, busulfan, bleomycin, penicillamine, nitrofuratoin, methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the clinical presentation

A
  • progressive breathlessness (several years) usually on exertion
  • dry cough
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what would you find on examination?

A
  • clubbing

- bilateral fine inspiratory crackles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what do the fine inspiratory crackles suggest and why is this an issue?

A
  • fine, inspiratory crackles and breathlessness means that a lot of people are referred to cardiology with heart failure but it is important to keep IPF on the differential diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what investigations would be done?

A
  • pulmonary function tests
  • CXR
  • CT scan
  • Lung biopsy (this is not necessary is the CT scan is diagnostic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what would be found on pulmonary function tests?

A
  • there would be a restrictive defect

- reduced FEV1 and FVC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what would gas transfer be like?

A

low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what would the CXR show?

A

bilateral infiltrates however the CXR may be normal in individuals with early or limited disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what would the CT scan show?

A
  • reticulonodular fibrotic change which is worse at the lung bases
  • the presence of ground glass suggests reversible alveolitis
  • fibrosis is irreversible
  • typically demonstrates a patchy, predominantly peripheral, subpleural and basal reticular pattern
  • In more advanced disease: honeycombing cysts and traction bronchiectasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what should be on the differential diagnosis for this clinical presentation with investigations?

A
  • exclude occupational disease (asbestosis, Silicosis)
  • mitral valve disease - an echo is done to see if they have this
  • left ventricular failure
  • sarcoidosis
  • extrinsic allergic alveolitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what treatment options are there?

A

-it is frustratingly ineffective
steroid and immunosuppressants do not change the course of disease

  • N-acetyl cysteine may have anti-fibrotic effects via its antioxidant properties
  • Pirfenidone is a new antifibrotic drug - only therapy shown in randomised controlled trials to slow down disease progression BUT very expensive
  • Treatment is aimed at slowing future progression rather than reversing established fibrosis
  • oxygen if hypoxic
  • Pulmonary artery vasodilators - some patients with pulmonary fibrosis develop pulmonary hypertension
  • Future treatments : other anti-fibrotic agents e.g. Tyrosine Kinase Inhibitors
17
Q

what is a potential treatment option for young patients?

A

lung transplant

18
Q

what is the prognosis like ?

A

most patients progress into respiratory failure and are dead within 5 years